EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cell-Free DNA Release Kinetics and Fragmentation Reflect Treatment Response and Resistance In Vitro

Alexandra Bartolomucci iD, Laura Kienzle, Sarah Tadhg Ferrier iD, Benjamin Forgie iD, Thupten Tsering, Kyle Dickinson iD, Lorenzo Ferri iD, Jonathan Cools-Lartigue, Julia V Burnier

Cells · 2026

DOI: 10.3390/cells15171561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Alexandra Bartolomucci und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Cell-Free Nucleic Acids, DNA Fragmentation, Circulating Tumor DNA. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Cancer Society, Fonds de Recherche du Québec - Santé, Fonds de Recherche du Québec en Santé.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Circulating tumor DNA (ctDNA) has emerged as a clinically valuable biomarker for cancer detection, treatment monitoring, and minimal residual disease assessment. Despite its growing clinical utility, the biological mechanisms governing ctDNA release remain incompletely understood. The objective of this study was to investigate how chemotherapy-induced cytotoxicity and chemoresistance influence the kinetics and fragmentation patterns of cfDNA released by cancer cells in vitro.

Methods

Human lung adenocarcinoma (A549) and esophageal adenocarcinoma (FLO-1, OE19) cell lines were used to investigate cell-free DNA (cfDNA) release and fragmentation in vitro. Cancer cells were treated with chemotherapy (cisplatin and 5-fluorouracil), and cfDNA released into the culture medium was quantified as total cfDNA by Qubit fluorometry and mutation-specific cfDNA by droplet digital PCR (ddPCR). A cisplatin-resistant OE19 model was generated to directly compare cfDNA release kinetics between chemosensitive and chemoresistant cells. Fragment size distributions were determined and evaluated alongside cell death mechanisms assessed by flow cytometry. Results: cfDNA release correlated positively with viable tumor cell number across all cell lines. Chemotherapy increased per-cell cfDNA release in all cell lines. Chemosensitive OE19 cells exhibited significantly higher cfDNA release compared to chemoresistant OE19 cells following cisplatin exposure, with distinct temporal release kinetics. Additionally, chemotherapy treatment induced a shift toward the release of larger DNA fragments in both chemosensitive and resistant cells. This was accompanied by changes in PI-positive and Annexin V/PI double-positive cell populations, suggesting altered cell death processes following cisplatin treatment.

Conclusions

Chemotherapy-induced cytotoxicity significantly influences cfDNA release kinetics and fragmentation patterns, with distinct effects in chemosensitive and chemoresistant cancer cells. These findings provide mechanistic insight into tumor-derived DNA release biology and may have important implications for the interpretation, timing, and standardization of liquid biopsy testing during treatment. Furthermore, they establish in vitro cancer models as a valuable platform for studying cfDNA dynamics and informing preclinical therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmCell-Free Nucleic AcidsDNA FragmentationCirculating Tumor DNAHumansKineticsCell Line, TumorCisplatinAntineoplastic AgentsFluorouracil

Stichwörter der Autor:innen

biomarkercfDNAchemotherapy resistancectDNAesophageal adenocarcinomatreatment response

Substanzen

CisplatinCell-Free Nucleic AcidsAntineoplastic AgentsFluorouracilCirculating Tumor DNA

Autor:innen und Institutionen

  • Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
  • Department of Pathology, McGill University, Montreal, QC H3A 2B4, Canada.
  • Division of Thoracic Surgery, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
  • Gerald Bronfman Department of Oncology, McGill University, Montreal, QC H4A 3T2, Canada.
  • Goodman Cancer Institute, McGill University, Montreal, QC H3A 1A3, Canada.

ORCID-Profile: Alexandra Bartolomucci, Sarah Tadhg Ferrier, Benjamin Forgie, Kyle Dickinson, Lorenzo Ferri

Förderung

  • Canadian Cancer Society
  • Fonds de Recherche du Québec - Santé
  • Fonds de Recherche du Québec en Santé

Zitieren

APA

Bartolomucci, A., Kienzle, L., Ferrier, S. T., Forgie, B., Tsering, T., Dickinson, K., Ferri, L., Cools-Lartigue, J., & Burnier, J. V. (2026). Cell-Free DNA Release Kinetics and Fragmentation Reflect Treatment Response and Resistance In Vitro. Cells. https://doi.org/10.3390/cells15171561

Vancouver

Bartolomucci A, Kienzle L, Ferrier ST, Forgie B, Tsering T, Dickinson K, et al. Cell-Free DNA Release Kinetics and Fragmentation Reflect Treatment Response and Resistance In Vitro. Cells. 2026. doi:10.3390/cells15171561

BibTeX
@article{Bartolomucci2026,
  author = {Bartolomucci, Alexandra and Kienzle, Laura and Ferrier, Sarah Tadhg and Forgie, Benjamin and Tsering, Thupten and Dickinson, Kyle and Ferri, Lorenzo and Cools-Lartigue, Jonathan and Burnier, Julia V},
  title = {Cell-Free DNA Release Kinetics and Fragmentation Reflect Treatment Response and Resistance In Vitro},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15171561}
}
Kostenlos starten →